Literature DB >> 9252211

A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey.

H V Thomas1, T J Key, D S Allen, J W Moore, M Dowsett, I S Fentiman, D Y Wang.   

Abstract

The associations between serum concentrations of oestradiol, testosterone and sex hormone-binding globulin (SHBG) and risk of breast cancer in post-menopausal women were investigated in a prospective study on the island of Guernsey. Sixty-one women who developed breast cancer an average of 7.8 years after blood collection were matched for age, year of blood collection and number of years post-menopausal with 179 control subjects. Women using exogenous hormones at the time of blood collection were excluded from the study. Women who subsequently developed breast cancer had a 29% higher geometric mean oestradiol concentration than control women (P = 0.004). The odds ratio for breast cancer in the top third compared with the lowest third of the oestradiol concentration distribution was 5.03 (95% confidence interval 2.02-12.49, P for trend < 0.001). Adjusting for testosterone and SHBG concentrations did not substantially alter the odds ratio for oestradiol. Although testosterone and SHBG concentrations were associated with breast cancer risk, the concentrations of these hormones were correlated with those of oestradiol; the associations were not statistically significant after adjusting for oestradiol concentration. These data provide evidence that serum oestradiol concentrations in post-menopausal women may have a substantial effect on breast cancer risk.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9252211      PMCID: PMC2224063          DOI: 10.1038/bjc.1997.398

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

1.  Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.

Authors:  J F Dorgan; C Longcope; H E Stephenson; R T Falk; R Miller; C Franz; L Kahle; W S Campbell; J A Tangrea; A Schatzkin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-07       Impact factor: 4.254

2.  Binding of oestradiol to blood proteins and aetiology of breast cancer.

Authors:  J W Moore; G M Clark; S A Hoare; R R Millis; J L Hayward; M K Quinlan; D Y Wang; R D Bulbrook
Journal:  Int J Cancer       Date:  1986-11-15       Impact factor: 7.396

3.  Androgens in breast cancer. II. Endometrial adenocarcinoma and breast cancer in married postmenopausal women.

Authors:  R Grattarola; G Secreto; C Recchione; W Castellini
Journal:  Am J Obstet Gynecol       Date:  1974-01-15       Impact factor: 8.661

4.  Sex hormone levels in serum in relation to the development of breast cancer.

Authors:  D K Wysowski; G W Comstock; K J Helsing; H L Lau
Journal:  Am J Epidemiol       Date:  1987-05       Impact factor: 4.897

5.  Plasma testosterone and breast cancer.

Authors:  P Hill; L Garbaczewski; F Kasumi
Journal:  Eur J Cancer Clin Oncol       Date:  1985-10

Review 6.  Endogenous hormones as a major factor in human cancer.

Authors:  B E Henderson; R K Ross; M C Pike; J T Casagrande
Journal:  Cancer Res       Date:  1982-08       Impact factor: 12.701

7.  Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls.

Authors:  H O Adami; E D Johansson; J Vegelius; A Victor
Journal:  Ups J Med Sci       Date:  1979       Impact factor: 2.384

8.  A liquid-phase immunoradiometric assay (IRMA) for human sex hormone binding globulin (SHBG).

Authors:  G L Hammond; M S Langley; P A Robinson
Journal:  J Steroid Biochem       Date:  1985-10       Impact factor: 4.292

9.  Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route.

Authors:  M Dowsett; P E Goss; T J Powles; G Hutchinson; A M Brodie; S L Jeffcoate; R C Coombes
Journal:  Cancer Res       Date:  1987-04-01       Impact factor: 12.701

10.  Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients.

Authors:  G Secreto; C Recchione; A Cavalleri; M Miraglia; V Dati
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640

View more
  34 in total

1.  Increased proteasome-dependent degradation of estrogen receptor-alpha by TGF-beta1 in breast cancer cell lines.

Authors:  Trevor A Petrel; Robert W Brueggemeier
Journal:  J Cell Biochem       Date:  2003-01-01       Impact factor: 4.429

Review 2.  The role of estrogen in the initiation of breast cancer.

Authors:  J Russo; Irma H Russo
Journal:  J Steroid Biochem Mol Biol       Date:  2006-12       Impact factor: 4.292

3.  Combined profile of the tandem repeats CAG, TA and CA of the androgen and estrogen receptor genes in breast cancer.

Authors:  Andrei Anghel; Marius Raica; Catalin Marian; Sorin Ursoniu; Oana Mitrasca
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-22       Impact factor: 4.553

4.  Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk.

Authors:  Susan E Hankinson; A Heather Eliassen
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-24       Impact factor: 4.292

Review 5.  Sex hormone-binding globulin: not only a transport protein. What news is around the corner?

Authors:  N Fortunati
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

Review 6.  Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression.

Authors:  Priya Bhardwaj; CheukMan C Au; Alberto Benito-Martin; Heta Ladumor; Sofya Oshchepkova; Ruth Moges; Kristy A Brown
Journal:  J Steroid Biochem Mol Biol       Date:  2019-03-06       Impact factor: 4.292

7.  Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study.

Authors:  Christy G Woolcott; Yurii B Shvetsov; Frank Z Stanczyk; Lynne R Wilkens; Kami K White; Christian Caberto; Brian E Henderson; Loïc Le Marchand; Laurence N Kolonel; Marc T Goodman
Journal:  Endocr Relat Cancer       Date:  2010-02-18       Impact factor: 5.678

8.  Estradiol enhances sociosexual behavior and can have proliferative effects in ovariectomized rats.

Authors:  Alicia A Walf; Cheryl A Frye
Journal:  Age (Dordr)       Date:  2008-10-29

9.  Serum oestrogen receptor alpha and beta bioactivity are independently associated with breast cancer: a proof of principle study.

Authors:  M Widschwendter; H Lichtenberg-Frate; G Hasenbrink; S Schwarzer; A Dawnay; A Lam; U Menon; S Apostolidou; E Raum; C Stegmaier; I J Jacobs; H Brenner
Journal:  Br J Cancer       Date:  2009-06-02       Impact factor: 7.640

10.  Urinary endogenous sex hormone levels and the risk of postmenopausal breast cancer.

Authors:  N C Onland-Moret; R Kaaks; P A H van Noord; S Rinaldi; T Key; D E Grobbee; P H M Peeters
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.